A new study shows that a biomedical tool can successfully deliver genetic material to edit faulty genes in developing fetal ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...

On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $52.8 which represents a decrease of $-0.59 or -1.11% from the prior close of $53.39. The stock opened at $53.39 and touched a ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

With exclusive FDA insight, the 4th mRNA Analytical Development & Quality Control Summit returns; uniting the Analytical, ...

A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

Scientists in Australia have found why mRNA vaccines trigger side effects, paving the way for more effective vaccines.

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent patients aged 5 years and older.

As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...